Loading clinical trials...
Loading clinical trials...
Comparision of the Outcomes and Learning Curve of Rectectomy for Rectal Cancer Using Diverse Minimally Technologies: Surgical Robot "Micro Hand S", Laparoscope
Central South University in collaboration with Tianjin University developed the first domestically produced Chinese minimally invasive surgical (MIS) robot system which named "Micro Hand S" in 2013. This new MIS robot had been authorized to enter the clinical trial stage by the Ethics Committee of the Third Xiangya Hospital at Central South University. The Micro Hand S robot is safe and feasible in the preliminary study. However, compared with minimally invasive approaches (da Vici, laparoscope), the merits and demrits of rectectomy for rectal cancer are unclear. Therefore, the investigators conduct this retrospective study to focus on this concern.
Age
18 - 80 years
Sex
ALL
Healthy Volunteers
No
The Third Xiangya Hospital of Central South University
Changsha, Hunan, China
Start Date
July 1, 2015
Primary Completion Date
November 30, 2018
Completion Date
December 31, 2019
Last Updated
April 8, 2021
105
ACTUAL participants
Micro Hand S robot
DEVICE
Laparoscope
DEVICE
Lead Sponsor
The Third Xiangya Hospital of Central South University
NCT06696768
NCT04929028
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions